BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24345887)

  • 1. Towards personalized care in IBD.
    Gerich ME; McGovern DP
    Nat Rev Gastroenterol Hepatol; 2014 May; 11(5):287-99. PubMed ID: 24345887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review article: genetic susceptibility and application of genetic testing in clinical management of inflammatory bowel disease.
    Vermeire S
    Aliment Pharmacol Ther; 2006 Oct; 24 Suppl 3():2-10. PubMed ID: 16961737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostics of inflammatory bowel disease.
    Nikolaus S; Schreiber S
    Gastroenterology; 2007 Nov; 133(5):1670-89. PubMed ID: 17983810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards a novel molecular classification of IBD.
    Vermeire S
    Dig Dis; 2012; 30(4):425-7. PubMed ID: 22796810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnostic biomarkers in inflammatory bowel disease].
    Kanmura S; Sakiyama T; Uto H; Tsubouchi H
    Nihon Rinsho; 2012 May; 70(5):790-5. PubMed ID: 22620002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of genotype-phenotype relationships and stratification by the CARD15 variant genotype for inflammatory bowel disease susceptibility loci using multiple short tandem repeat genetic markers.
    Crawford NP; Colliver DW; Funke AA; Young MN; Kelley S; Cobbs GA; Petras RE; Galandiuk S
    Hum Mutat; 2005 Feb; 25(2):156-66. PubMed ID: 15643611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular pathogenesis of inflammatory bowel disease: genotypes, phenotypes and personalized medicine.
    Goyette P; Labbé C; Trinh TT; Xavier RJ; Rioux JD
    Ann Med; 2007; 39(3):177-99. PubMed ID: 17457716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in the molecular dissection of inflammatory bowel disease.
    Siminovitch KA
    Semin Immunol; 2006 Aug; 18(4):244-53. PubMed ID: 16679026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis.
    Karlsen TH; Hampe J; Wiencke K; Schrumpf E; Thorsby E; Lie BA; Broomé U; Schreiber S; Boberg KM
    Am J Gastroenterol; 2007 Jan; 102(1):115-21. PubMed ID: 17100974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Personalizing therapy for inflammatory bowel diseases.
    Ananthakrishnan AN
    Expert Rev Gastroenterol Hepatol; 2013 Aug; 7(6):549-58. PubMed ID: 23985004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monogenic diseases associated with intestinal inflammation: implications for the understanding of inflammatory bowel disease.
    Uhlig HH
    Gut; 2013 Dec; 62(12):1795-805. PubMed ID: 24203055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological markers in inflammatory bowel disease: practical consideration for clinicians.
    Mendoza JL; Abreu MT
    Gastroenterol Clin Biol; 2009 Jun; 33 Suppl 3():S158-73. PubMed ID: 20117339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal mucosal immune response to altered bacterial flora following restorative proctocolectomy in patients with ulcerative colitis: serologic measures, immunogenetics, and clinical correlations.
    Sheikh S; Uno J; Matsuoka K; Plevy S
    Clin Immunol; 2008 Jun; 127(3):270-9. PubMed ID: 18499066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease.
    Cantor MJ; Nickerson P; Bernstein CN
    Am J Gastroenterol; 2005 May; 100(5):1134-42. PubMed ID: 15842590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune aspects of the pathogenesis of inflammatory bowel disease.
    Hisamatsu T; Kanai T; Mikami Y; Yoneno K; Matsuoka K; Hibi T
    Pharmacol Ther; 2013 Mar; 137(3):283-97. PubMed ID: 23103332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management consensus of inflammatory bowel disease for the Asia-Pacific region.
    Ouyang Q; Tandon R; Goh KL; Pan GZ; Fock KM; Fiocchi C; Lam SK; Xiao SD
    J Gastroenterol Hepatol; 2006 Dec; 21(12):1772-82. PubMed ID: 17074013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serologic markers: impact on early diagnosis and disease stratification in inflammatory bowel disease.
    Arai R
    Postgrad Med; 2010 Jul; 122(4):177-85. PubMed ID: 20675980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory bowel disease genetics: Nod2.
    Cho JH; Abraham C
    Annu Rev Med; 2007; 58():401-16. PubMed ID: 16987083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nutrigenetics, nutrigenomics and inflammatory bowel diseases.
    Ferguson LR
    Expert Rev Clin Immunol; 2013 Aug; 9(8):717-26. PubMed ID: 23971750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.